• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Abattis' Northern Vine Labs Receives Controlled Substance License

October 3, 2016

 

 

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is pleased to announce that Northern Vine has received a letter from Health Canada and a copy of the license informing that it is now an authorized Licensed Dealer.

 

"We wish to congratulate the Northern Vine team on this important milestone for the Company. We have remained patient in obtaining this licence.  We persevered and were granted Licence No. 2016/6368 for our Northern Vine facility. 

 

‘The  licence  allows  for  the  analytical  testing  of    samples of  cannabis  received  from  holders  of  a  valid licence  issued  under  the  Narcotic  Control  Regulations,  the  Access to  Cannabis  for  Medical  Purposes Regulators  or  from  an  individual  authorized  by  a  valid  exemption  under  the  Controlled  Drugs  and Substances  Act  to  provide,  deliver,  transport  or  send  fresh  or  dried  marijuana  or  cannabis  to  licensed dealers for the purposes of analytical testing'

 

"The Northern Vine facility would be one of the only testing facilities in the Lower Mainland of British Columbia and one of 18 in Canada.  Abattis is very proud of this accomplishment and is looking forward to moving to the revenue and growth stage of the Company for its investors and stakeholders.   We are grateful for the support of the shareholders, staff, board of directors and are excited about the future prospect of Abattis and its related companies", said Rene David, Director of Northern Vine and Individual in Charge of the Premises. 

 

Further reading on the importance of testing facilities on the quality of medical marijuana please see here.

 

Katherine Maloney, Qualified Person in Charge at the Northern Vine Canada facility provides the following information.  “We can test for any approved patients or licensed producers.  We will test for potency, constituency, microbial, foreign matter for dried marijuana and oils.  Our license includes research and product development, as well as production of base materials. Northern Vine continues to explore different testing methodologies with BCIT.  We intend to expand our list of approved cannabinoids and intend to file an amendment to expand on the list.”  Northern Vine seeks to become the premier analytical testing laboratory and research and development partner to the legal cannabis industry in Canada.  Northern Vine will be known for: neutral, credible and reliable third party testing service, highest quality, accuracy, speed and competitive pricing.

 

About Abattis Bioceuticals Corp.

Abattis is a specialty biotechnology company that aggregates, incubates, integrates, and invests in the botanical drug development industry. The Company develops and licenses natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets – some of which will contain cannabinoid compounds. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.

 

About Northern Vine Canada Inc.

Northern Vine Labs™ is licensed by Health Canada for the possession of Cannabis and related active ingredients, as well as the production of extracts for the purpose of analysis.Northern Vine Labs™ product certification and quality assurances programs incorporate global best practices and procedures for application in the Canadian market.

 

ON BEHALF OF THE BOARD

"Rene David"

Rene David, CFO and Interim CEO

 

For further information, contact the Company at (604) 336-0881 or at news@abattis.com. 

 

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.     

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.